These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 20573060

  • 21. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R, Cease K, Troeschel S, Zhao L, Gross M, Chen G, Chopra V, Ramnath N.
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [Abstract] [Full Text] [Related]

  • 22. Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.
    Gregory DL, Hicks RJ, Hogg A, Binns DS, Shum PL, Milner A, Link E, Ball DL, Mac Manus MP.
    J Nucl Med; 2012 Jul; 53(7):1007-15. PubMed ID: 22677701
    [Abstract] [Full Text] [Related]

  • 23. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
    Lee HY, Chung JK, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC.
    Ann Nucl Med; 2008 May; 22(4):281-6. PubMed ID: 18535878
    [Abstract] [Full Text] [Related]

  • 24. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
    Lardinois D, Weder W, Roudas M, von Schulthess GK, Tutic M, Moch H, Stahel RA, Steinert HC.
    J Clin Oncol; 2005 Oct 01; 23(28):6846-53. PubMed ID: 16192576
    [Abstract] [Full Text] [Related]

  • 25. [Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
    Liu SW, Yu JM, Xing LG.
    Zhonghua Zhong Liu Za Zhi; 2004 Oct 01; 26(10):626-9. PubMed ID: 15634527
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer.
    Deuschl C, Nensa F, Grueneisen J, Poeppel TD, Sawicki LM, Heusch P, Gramsch C, Mönninghoff C, Quick HH, Forsting M, Umutlu L, Schlamann M.
    Acta Radiol; 2017 Aug 01; 58(8):991-996. PubMed ID: 28273734
    [Abstract] [Full Text] [Related]

  • 27. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M, Wu N, Liang Y, Zheng R, Liu Y, Zhang WJ, Zhao P.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr 01; 31(4):288-92. PubMed ID: 19615286
    [Abstract] [Full Text] [Related]

  • 28. Prognosis and reevaluation of lung cancer by positron emission tomography imaging.
    Erasmus JJ, Rohren E, Swisher SG.
    Proc Am Thorac Soc; 2009 Apr 15; 6(2):171-9. PubMed ID: 19349485
    [Abstract] [Full Text] [Related]

  • 29. The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
    Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Govindan R.
    J Thorac Oncol; 2008 Feb 15; 3(2):135-9. PubMed ID: 18303433
    [Abstract] [Full Text] [Related]

  • 30. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.
    Ohno Y, Koyama H, Yoshikawa T, Takenaka D, Seki S, Yui M, Yamagata H, Aoyagi K, Matsumoto S, Sugimura K.
    Radiology; 2015 Jun 15; 275(3):849-61. PubMed ID: 25584709
    [Abstract] [Full Text] [Related]

  • 31. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer.
    Kamel EM, Zwahlen D, Wyss MT, Stumpe KD, von Schulthess GK, Steinert HC.
    J Nucl Med; 2003 Dec 15; 44(12):1911-7. PubMed ID: 14660716
    [Abstract] [Full Text] [Related]

  • 32. Value of positron emission tomography for lung cancer staging.
    Albes JM, Dohmen BM, Schott U, Schülen E, Wehrmann M, Ziemer G.
    Eur J Surg Oncol; 2002 Feb 15; 28(1):55-62. PubMed ID: 11869015
    [Abstract] [Full Text] [Related]

  • 33. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy.
    Eschmann SM, Friedel G, Paulsen F, Budach W, Harer-Mouline C, Dohmen BM, Bares R.
    Eur J Nucl Med Mol Imaging; 2002 Jun 15; 29(6):804-8. PubMed ID: 12029555
    [Abstract] [Full Text] [Related]

  • 34. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
    Gómez-Caro A, Garcia S, Reguart N, Arguis P, Sanchez M, Gimferrer JM, Marrades R, Lomeña F.
    Eur J Cardiothorac Surg; 2010 May 15; 37(5):1168-74. PubMed ID: 20116273
    [Abstract] [Full Text] [Related]

  • 35. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2009 Jul 15; 50(6):638-44. PubMed ID: 19492198
    [Abstract] [Full Text] [Related]

  • 36. Positron emission tomography imaging in nonsmall-cell lung cancer.
    Erasmus JJ, Macapinlac HA, Swisher SG.
    Cancer; 2007 Nov 15; 110(10):2155-68. PubMed ID: 17896784
    [Abstract] [Full Text] [Related]

  • 37. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 15; 30(4):306-9. PubMed ID: 18788639
    [Abstract] [Full Text] [Related]

  • 38. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.
    Clin Nucl Med; 2007 Aug 15; 32(8):607-12. PubMed ID: 17667432
    [Abstract] [Full Text] [Related]

  • 39. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A.
    Thorax; 2007 Aug 15; 62(8):696-701. PubMed ID: 17687098
    [Abstract] [Full Text] [Related]

  • 40. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK, Jeon K, Koh WJ, Suh GY, Kim H, Kwon OJ, Chung MP, Lee KS, Shim YM, Han J, Um SW.
    Respirology; 2010 Nov 15; 15(8):1179-84. PubMed ID: 20573058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.